TP53 and cancer: However, TP53 is extremely susceptible to mutating all cancer types (Zhu et al., 2015; Sabapathy and Lane, 2019), it undergoes a variety of mutations such as point mutation, deletion, frameshift and rearrangement (Wu et al., 2020).